July 10, 2026
Commission VI of the DPR RI Reviews Phapros, Encourages the Strengthening of National Pharmaceutical Industry Independence
Phapros received a Specific Working Visit from Commission VI of the House of Representatives of the Republic of Indonesia (DPR RI) at the Simongan Factory, Semarang, on Friday (10/7). ...
See More
June 21, 2026
Celebrating a 72-Year Journey, Phapros Conducts Various Real Actions for the Community & Environment
SEMARANG, June 21, 2026 – PT Phapros Tbk ("PEHA"), a leading pharmaceutical company in Indonesia, has been on a 72-year journey (June 21, 1954 – June 21, 2026) contributing to Indonesia's health. The peak of the celebration series, themed "Phapros is Healthy, Healthy is Phapros," was held at the Phapros Simongan Factory, Semarang on Sunday, June 21, 2026...
See More
June 11, 2026
Successfully Printing 109% Profit Growth in 2025, Phapros (PEHA) Distributes 15% Dividend
PT Phapros Tbk ("PEHA"), a leading pharmaceutical company in Indonesia, has successfully held its Annual General Meeting of Shareholders (AGMS) in Jakarta, Thursday, June 11, 2026....
See More
June 11, 2026
Executing 5 Strategic Steps, Phapros (PEHA) is Optimistic to Continue the Positive Trend of Sales & Net Profit Growth Throughout 2026
PT Phapros Tbk ("PEHA"), a leading pharmaceutical company in Indonesia, is optimistic about continuing the positive trend of its financial performance in 2026. ...
See More
April 28, 2026
Successfully Holds Extraordinary General Meeting of Shareholders, Phapros (PEHA) Appoints Intan Abdams Katoppo as New Captain
JAKARTA, April 28, 2026 – PT Phapros Tbk (PEHA), a leading pharmaceutical company in Indonesia, successfully held an Extraordinary General Meeting of Shareholders (EGMS/RUPS-LB) in Jakarta on Monday, April 27, 2026....
See More
April 21, 2026
Continuing the Success of 2025, Phapros (PEHA) Successfully Records Net Profit Growth of 113% in Quarter 1/2026
In the first three months of 2026, Phapros once again posted significant net profit growth reaching 112.86% y-o-y....
See More